The Food and Drug Administration (FDA) in the United States has approved Gilead Science Inc’s (GILD.O) drug remdesivir for emergency use against COVID-19.
On Friday, 1 May, President Donald Trump announced the news at the white house. Stephen Hahn, the Food and Drug Administration (FDA) commissioner too was present and said, remdesivir would be available for hospitalized COVID-19 patients, The Guardian reported.